A detailed history of Accredited Investors Inc. transactions in Dexcom Inc stock. As of the latest transaction made, Accredited Investors Inc. holds 4,507 shares of DXCM stock, worth $317,653. This represents 0.03% of its overall portfolio holdings.

Number of Shares
4,507
Previous 4,643 2.93%
Holding current value
$317,653
Previous $643,000 20.53%
% of portfolio
0.03%
Previous 0.04%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$110.31 - $140.45 $15,002 - $19,101
-136 Reduced 2.93%
4,507 $511,000
Q1 2024

May 14, 2024

BUY
$114.22 - $140.1 $14,848 - $18,213
130 Added 2.88%
4,643 $643,000
Q2 2023

Aug 03, 2023

SELL
$112.47 - $130.98 $43,750 - $50,951
-389 Reduced 7.94%
4,513 $579,000
Q4 2022

Feb 07, 2023

BUY
$84.98 - $122.67 $169 - $245
2 Added 0.04%
4,902 $555,000
Q3 2022

Nov 08, 2022

SELL
$76.35 - $94.18 $7,634 - $9,418
-100 Reduced 2.0%
4,900 $395,000
Q2 2022

Jul 21, 2022

BUY
$67.99 - $132.89 $254,826 - $498,071
3,748 Added 299.36%
5,000 $373,000
Q1 2022

May 06, 2022

BUY
$94.08 - $130.2 $376 - $520
4 Added 0.32%
1,252 $641,000
Q3 2021

Nov 12, 2021

SELL
$106.71 - $143.18 $2,881 - $3,865
-27 Reduced 2.12%
1,248 $682,000
Q2 2021

Jul 30, 2021

SELL
$80.99 - $107.93 $4,616 - $6,152
-57 Reduced 4.28%
1,275 $544,000
Q1 2021

Apr 16, 2021

SELL
$84.79 - $104.74 $21,451 - $26,499
-253 Reduced 15.96%
1,332 $479,000
Q3 2020

Nov 05, 2020

SELL
$95.51 - $112.95 $6,781 - $8,019
-71 Reduced 4.29%
1,585 $163,000
Q2 2020

Jul 29, 2020

SELL
$62.68 - $105.34 $7,270 - $12,219
-116 Reduced 6.55%
1,656 $671,000
Q1 2020

May 15, 2020

SELL
$47.79 - $75.63 $19,307 - $30,554
-404 Reduced 18.57%
1,772 $477,000
Q2 2019

Aug 13, 2019

SELL
$27.84 - $38.92 $3,480 - $4,865
-125 Reduced 5.43%
2,176 $0
Q1 2019

Apr 17, 2019

BUY
$28.07 - $38.18 $5,417 - $7,368
193 Added 9.16%
2,301 $274,000
Q4 2018

Feb 13, 2019

SELL
$26.99 - $37.37 $6,990 - $9,678
-259 Reduced 10.94%
2,108 $253,000
Q2 2018

Jul 31, 2018

BUY
$17.54 - $25.22 $41,517 - $59,695
2,367 New
2,367 $225,000

Others Institutions Holding DXCM

About DEXCOM INC


  • Ticker DXCM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 386,257,984
  • Market Cap $27.2B
  • Description
  • DexCom, Inc., a medical device company, focuses on the design, development, and commercialization of continuous glucose monitoring (CGM) systems in the United States and internationally. The company provides its systems for use by people with diabetes, as well as for use by healthcare providers. Its products include DexCom G6, an integrated CGM ...
More about DXCM
Track This Portfolio

Track Accredited Investors Inc. Portfolio

Follow Accredited Investors Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Accredited Investors Inc., based on Form 13F filings with the SEC.

News

Stay updated on Accredited Investors Inc. with notifications on news.